BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35384455)

  • 1. The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.
    Bonneau S; Tong CM; Yang Y; Harissi-Dagher M
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2781-2790. PubMed ID: 35384455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term Interim Results of Clinical Outcomes and Complications After Implantation of Boston Keratoprosthesis in Japanese Patients.
    Ono T; Mori Y; Nejima R; Iwasaki T; Fukuda M; Minami K; Miyata K
    Cornea; 2020 Nov; 39 Suppl 1():S28-S33. PubMed ID: 32925428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type I keratoprosthesis: Review.
    Magalhães FP; Sousa LB; Oliveira LA
    Arq Bras Oftalmol; 2012; 75(3):218-22. PubMed ID: 22872210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Clinical Efficacy of Boston Keratoprosthesis Type I and Repetitive Penetrating Keratoplasty for Refractory Keratopathy.
    Chen Y; Wang C; Liu Q; Wang Z; Gao M
    J Craniofac Surg; 2020; 31(2):e194-e199. PubMed ID: 31977683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma after penetrating keratoplasty and keratoprosthesis.
    Khair D; El-Khoury J; Thompson P; Racine L; Harissi-Dagher M
    J Fr Ophtalmol; 2024 Mar; 47(3):104023. PubMed ID: 37973521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A multicenter clinical trial of collar-button type keratoprosthesis implantation for the treatment of corneal blindness in high-risk transplantation].
    Zhang T; Wang LL; Gu JJ; Xu JJ; Chen W; Huang YF; Hong JX; Wang T; Li SX; Gao H; Wang JT; Shi WY
    Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):262-271. PubMed ID: 37012589
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Boston keratoprosthesis].
    Wang L; Huang Y; James C; Dohlman CH
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boston Type 1 Keratoprosthesis: Updated Perspectives.
    Nonpassopon M; Niparugs M; Cortina MS
    Clin Ophthalmol; 2020; 14():1189-1200. PubMed ID: 32425503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.
    Lin M; Bhatt A; Haider A; Kim G; Farid M; Schmutz M; Mosaed S
    PLoS One; 2017; 12(8):e0182190. PubMed ID: 28777800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.
    Kosker M; Suri K; Rapuano CJ; Ayres BD; Nagra PK; Raber IM; Hammersmith KM
    Cornea; 2015 Sep; 34(9):1057-62. PubMed ID: 26114818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-year follow-up of penetrating keratoplasty.
    Ono T; Ishiyama S; Hayashidera T; Mori Y; Nejima R; Miyata K; Amano S
    Jpn J Ophthalmol; 2017 Mar; 61(2):131-136. PubMed ID: 27885526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston keratoprosthesis.
    Saeed HN; Shanbhag S; Chodosh J
    Curr Opin Ophthalmol; 2017 Jul; 28(4):390-396. PubMed ID: 28383302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study.
    Price MO; Gorovoy M; Benetz BA; Price FW; Menegay HJ; Debanne SM; Lass JH
    Ophthalmology; 2010 Mar; 117(3):438-44. PubMed ID: 20031230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boston type 1 keratoprosthesis outcomes in ocular burns.
    Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
    Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descemet stripping automated endothelialkeratoplasty (DSAEK) versus repeat penetrating keratoplasty (PKP) to manage eyes with failed corneal graft.
    Khairallah A
    Ann Saudi Med; 2018; 38(1):36-41. PubMed ID: 29419526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of penetrating keratoplasty and vitreoretinal surgery with Eckardt temporary keratoprosthesis in ocular trauma versus non-trauma patients.
    Bové Álvarez M; Arumí CG; Distéfano L; Güell JL; Gris Ó; Mateo C; Corcóstegui B; García-Arumí J
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2547-2558. PubMed ID: 31363832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Boston keratoprosthesis type 1].
    Harissi-Dagher M; Slim E
    J Fr Ophtalmol; 2019 Mar; 42(3):295-302. PubMed ID: 30857801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Vision-Related Quality of Life After Boston Type I Keratoprosthesis.
    Bostan C; Elfekhfakh M; Harissi-Dagher M
    Cornea; 2020 Feb; 39(2):222-228. PubMed ID: 31490275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes of penetrating keratoplasty versus Descemet's stripping automated endothelial keratoplasty for penetrating keratoplasty graft failure due to corneal edema.
    Kitzmann AS; Wandling GR; Sutphin JE; Goins KM; Wagoner MD
    Int Ophthalmol; 2012 Feb; 32(1):15-23. PubMed ID: 22271071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.